Cargando…
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of death worldwide and occurs with variable severity. There are few studies focused on the expression of soluble urokinase-type plasminogen activator receptor (suPAR) and syndecan-4 in patients with CAP. METHODS: A prospective, multi-ce...
Autores principales: | Luo, Qiongzhen, Ning, Pu, Zheng, Yali, Shang, Ying, Zhou, Bing, Gao, Zhancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784729/ https://www.ncbi.nlm.nih.gov/pubmed/29368632 http://dx.doi.org/10.1186/s13054-018-1943-y |
Ejemplares similares
-
suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014) -
suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009) -
suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022) -
suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012) -
Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)